Product Information
GABAPENTIN 600 MG TABLET is a generic product labeled by TAGI Pharma Inc., priced at $0.0703 per EA under NDC 51224002160. Its NADAC has been published 333 times since Jul 10, 2019.
FDA first approved this application on Oct 26, 2017. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
TAGI Pharma Inc.NDC
51224002160
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA207057FDA Approved
10/26/2017
TE Code
AB1
On Market Since
5/1/2019
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 600 MG TABLET has been published 333 times since Jul 10, 2019, and over the history we have for it it has declined 26.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0703 per EA |
|---|---|
| All-time high | $0.1086 (Jan 10, 2024) |
| All-time low | $0.0602 (Nov 20, 2024) |
| 52-week high | $0.0750 |
| 52-week low | $0.0703 |
| Median price | $0.0965 |
| Average price | $0.0937 |
| Largest weekly change | -36.7% (Nov 20, 2024) |
| Weeks tracked | 333 |
| Tracking since | Jul 10, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-6.2%
3Y
-26.9%
5Y
-33.1%
All
-26.5%
Last surveyed Nov 19, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 600 MG TABLET, manufactured by TAGI Pharma Inc., is $0.0703 per EA (NDC 51224002160), effective Nov 19, 2025.
How has the price of GABAPENTIN 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 600 MG TABLET has declined 26.5%. It has been tracked across 333 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 600 MG TABLET?
Since Jul 10, 2019, the NADAC for GABAPENTIN 600 MG TABLET has ranged from a low of $0.0602 (Nov 20, 2024) to a high of $0.1086 (Jan 10, 2024), with a median of $0.0965 per EA.
Are there cheaper alternatives to GABAPENTIN 600 MG TABLET?
Yes. 21 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 600 MG TABLET, is $0.0638 per EA — about 9% below GABAPENTIN 600 MG TABLET.
Who manufactures GABAPENTIN 600 MG TABLET?
GABAPENTIN 600 MG TABLET (NDC 51224002160) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.